Table 4
Schedule of enrolment, interventions and assessments
| Time point | Enrolment | Study period | ||||||||
| Preallocation | Allocation | Postallocation | ||||||||
| t2 | t1 | T1 | 0 | PA1 | HV1* | T2 | PA2 | T3 | PA3 | |
| Enrolment | ||||||||||
| Telephone screening |  | |||||||||
| Risk screening |  | |||||||||
| Medical screening |  | |||||||||
| Randomisation |  | |||||||||
| Assessment† | ||||||||||
| Baseline |  | |||||||||
| PA monitoring |  |  |  | |||||||
| Reassessment |  | |||||||||
| Follow-up |  | |||||||||
| Intervention (active intervention) | ||||||||||
| eLiFE |  | |||||||||
| aLiFE |  | |||||||||
| Control group |  | |||||||||
| Intervention (passive intervention) | ||||||||||
| eLiFE |  | |||||||||
| aLiFE |  | |||||||||
| Control group |  | |||||||||
PA monitoring/PA1, PA2, PA3 participants’ physical activity was monitored for 7 consecutive days. No contact to the research team was permitted during this time.
*Home visit (HV) 1 was completed 8–15 days after the baseline assessment.
†Outcome measures collected during the assessments are listed in table 3.
aLiFE, adapted LiFE; eLiFE, enhanced LiFE; PA, physical activity.